Literature DB >> 12244137

Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease.

Ali H Shah1, William B Tabayoyong, Simon Y Kimm, Seong-Jin Kim, Luk Van Parijs, Chung Lee.   

Abstract

TGF-beta regulation of immune homeostasis has been investigated in the context of cytokine knockout (TGF-beta null) mice, in which particular TGF-beta isoforms are disrupted throughout the entire organism, as well as in B and T cell-specific transgenic models, but to date the immunoregulatory effects of TGF-beta have not been addressed in the context of an in vivo mouse model in which multi-isoform TGF-beta signaling is abrogated in multiple leukocyte lineages while leaving nonhemopoietic tissue unaffected. Here we report the development of a murine model of TGF-beta insensitivity limited to the hemopoietic tissue of adult wild-type C57BL/6 mice based on retroviral-mediated gene transfer of a dominant negative TGF-beta type II receptor targeting murine bone marrow. Unlike the lymphoproliferative syndrome observed in TGF-beta1-deficient mice, the disruption of TGF-beta signaling in bone marrow-derived cells leads to dramatic expansion of myeloid cells, primarily monocytes/macrophages, and is associated with cachexia and mortality in lethally irradiated mice reconstituted with dominant negative receptor-transduced bone marrow. Surprisingly, there was a notable absence of T cell expansion in affected animals despite the observed differentiation of most cells in the T cell compartment to a memory phenotype. These results indicate not only that TGF-beta acts as a negative regulator of immune function, but that lack of functional TGF-beta signaling in the myeloid compartment of adult mice may trigger suppression of lymphocytes, which would otherwise proliferate when rendered insensitive to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244137     DOI: 10.4049/jimmunol.169.7.3485

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.

Authors:  Nengwang Yu; James M Kozlowski; Irwin I Park; Lin Chen; Qiang Zhang; Danfeng Xu; Jennifer A Doll; Susan E Crawford; Charles B Brendler; Chung Lee
Journal:  Urology       Date:  2010-10-27       Impact factor: 2.649

2.  TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function.

Authors:  Reena Rani; Alan G Smulian; David R Greaves; Simon P Hogan; De'Broski R Herbert
Journal:  Eur J Immunol       Date:  2011-05-27       Impact factor: 5.532

3.  A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner.

Authors:  Sung Ho Chen; Peih-Shan Wu; Chiang-Hung Chou; Yu-Ting Yan; Hsuan Liu; Shih-Yen Weng; Hsin-Fang Yang-Yen
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

4.  An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments.

Authors:  Jeong-Seok Nam; Masaki Terabe; Mizuko Mamura; Mi-Jin Kang; Helen Chae; Christina Stuelten; Ethan Kohn; Binwu Tang; Helen Sabzevari; Miriam R Anver; Scott Lawrence; David Danielpour; Scott Lonning; Jay A Berzofsky; Lalage M Wakefield
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 5.  Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.

Authors:  Jonathan P Andrews; Jaana Marttala; Edward Macarak; Joel Rosenbloom; Jouni Uitto
Journal:  Matrix Biol       Date:  2016-02-02       Impact factor: 11.583

6.  TGFβ signaling plays a critical role in promoting alternative macrophage activation.

Authors:  Dapeng Gong; Wei Shi; Sun-ju Yi; Hui Chen; John Groffen; Nora Heisterkamp
Journal:  BMC Immunol       Date:  2012-06-15       Impact factor: 3.615

7.  FGF-2, TGFbeta-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: an in vivo and in vitro study.

Authors:  Lucyene Miguita; Elizabeth Ferreira Martinez; Ney Soares de Araújo; Vera Cavalcanti de Araújo
Journal:  J Appl Oral Sci       Date:  2010 Jan-Feb       Impact factor: 2.698

Review 8.  Regulatory cells and transplantation tolerance.

Authors:  Stephen P Cobbold; Herman Waldmann
Journal:  Cold Spring Harb Perspect Med       Date:  2013-06-01       Impact factor: 6.915

9.  In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation.

Authors:  Paul M Vink; Wendy M Smout; Lilian J Driessen-Engels; Alex M de Bruin; Dianne Delsing; Magda A Krajnc-Franken; Aswin J Jansen; Eric F Rovers; André A van Puijenbroek; Allard Kaptein; Martijn A Nolte; Anja Garritsen; Hans van Eenennaam
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

10.  Relative roles of TGF-beta1 and Wnt in the systemic regulation and aging of satellite cell responses.

Authors:  Morgan E Carlson; Michael J Conboy; Michael Hsu; Laurel Barchas; Jaemin Jeong; Anshu Agrawal; Amanda J Mikels; Smita Agrawal; David V Schaffer; Irina M Conboy
Journal:  Aging Cell       Date:  2009-09-02       Impact factor: 9.304

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.